Essential nutrients: Food or supplements? Where should the emphasis be?

JAMA

Volumn 294, Issue 3, 2005, Pages 351-358

  Lichtenstein, Alice H ^a   Russell, Robert M ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; BETA CAROTENE;

BIOAVAILABILITY; CARDIOVASCULAR DISEASE; DIET SUPPLEMENTATION; FOOD INTAKE; HAZARD ASSESSMENT; HEALTH BEHAVIOR; HEALTH CARE POLICY; LUNG CANCER; MOLECULAR INTERACTION; NUTRIENT; NUTRITION; OUTCOMES RESEARCH; PRIORITY JOURNAL; PUBLIC HEALTH; PURIFICATION; REVIEW; RISK ASSESSMENT; TOXICITY; ARTICLE; DIET; HUMAN; MEDICAL RESEARCH; NUTRITIONAL REQUIREMENT; NUTRITIONAL VALUE; STANDARD; UNITED STATES;

BIOMEDICAL RESEARCH; DIET; DIETARY SUPPLEMENTS; FOOD, FORTIFIED; HUMANS; NUTRITION POLICY; NUTRITIONAL REQUIREMENTS; NUTRITIVE VALUE; UNITED STATES;

EID: 22244492982     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.294.3.351     Document Type: Review

References (125)

1. Institute of Medicine. How Should the Recommended Dietary Allowances Be Revised? Washington, DC: National Academy of Sciences; 1994.
2. Fletcher RH, Fairfield KM. Vitamins for chronic disease prevention in adults: clinical applications. JAMA. 2002;287:3127-3129.
3. Ness AR, Powles JW. Fruit and vegetables, and cardiovascular disease: a review. Int J Epidemiol. 1997; 26:1-13.
4. Law MR, Morris JK. By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease? Eur J Clin Nutr. 1998;52:549-556.
5. Appel LJ, Moore TJ, Obarzanek E, et al; and the DASH Collaborative Research Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336:1117-1124.
6. Sacks FM, Svetkey LP, Vollmer WM, et al. DASH-Sodium Collaborative Research Group: effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. N Engl J Med. 2001;344:3-10.
7. Lampe JW. Health effects of vegetables and fruit: assessing mechanisms of action in human experimental studies. Am J Clin Nutr. 1999;70(3 suppl):475S-490S.
8. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men.N Engl J Med. 1993;328:1450-1456.
9. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444-1449.
10. Boaz M, Smetana S, Weinstein T, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet. 2000;356:1213-1218.
11. Rapola JM, Virtamo J, Ripatti S, et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet. 1997;349:1715-1720.
12. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) Lancet. 1996;347:781-786.
13. Reaven PD, Khouw A, Beltz WF, Parthasarathy S, Witztum JL. Effect of dietary antioxidant combinations in humans: protection of LDL by vitamin E but not by beta-carotene. Arterioscler Thromb. 1993;13: 590-600.
14. Jialal I, Grundy SM. Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein. J Lipid Res. 1992; 33:899-906.
15. Osganian SK, Stampfer MJ, Rimm E, Spiegelman D, Manson JE, Willett WC. Dietary carotenoids and risk of coronary artery disease in women. Am J Clin Nutr. 2003;77:1390-1399.
16. Stampfer MJ, Colditz GA, Willett WC, et al. Postmenopausal estrogen therapy and cardiovascular disease: ten-year follow-up from the Nurses' Health Study. N Engl J Med. 1991;325:756-762.
17. Lonn E, Yusuf S, Hoogwerf B, et al. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Diabetes Care. 2002;25:1919-1927.
18. Hodis HN, Mack WJ, LaBree L, et al. Alphatocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). Circulation. 2002;106:1453-1459.
19. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002; 360:23-33.
20. de Gaetano G; and the Collaborative Group of the Primary Prevention Project. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet. 2001;357:89-95.
21. Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P; The Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med. 2000;342:154-160.
22. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSIPrevenzione trial. Lancet. 1999;354:447-455.
23. Virtamo J, Rapola JM, Ripatti S, et al. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch Intern Med. 1998;158:668-675.
24. Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med. 1996;334: 1145-1149.
25. Greenberg ER, Baron JA, Karagas MR, et al. Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation. JAMA. 1996;275:699-703.
26. Katz D, Evans M, Chan W, et al. Oats, antioxidants and endothelial function in overweight, dyslipidemic adults. J Am Coll Nutr. 2004;23:397-403.
27. Lonn E, Bosch J, Yusuf S, et al. Effects of longterm vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005;293:1338-1347.
28. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/ AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation. 2003; 107:149-158.
29. Kris-Etherton P, Lichtenstein AH, Howard B, et al. Antioxidant vitamin supplements and cardiovascular disease. Circulation. 2004;110:637-641.
30. Morris CD, Carson S. Routine vitamin supplementation to prevent cardiovascular disease: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med. J2003;139:56-70.
31. Eidelman RS, Hollar D, Hebert PR, Lamas GA, Hennekens CH. Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease. Arch Intern Med. 2004;164:1552-1556.
32. Shekelle PG, Morton SC, Jungvig LK, et al. Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease. J Gen Intern Med. 2004;19:380-389.
33. Michaud DS, Feskanich D, Rimm EB, et al. Intake of specific carotenoids and risk of lung cancer in 2 prospective US cohorts.Am J Clin Nutr. 2000;72:990-997.
34. Ziegler RG, Mayne ST, Swanson CA. Nutrition and lung cancer. Cancer Causes Control. 1996;7:157-177.
35. Mayne ST. Beta-carotene, carotenoids, and disease prevention in humans. FASEB J. 1996;10:690-701.
36. Peto R, Doll R, Buckley JD, Sporn MB. Can dietary beta-carotene materially reduce human cancer rates? Nature. 1981;290:201-208.
37. The Alpha-Tocopherol; Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994;330: 1029-1035.
38. Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med. 1996;334:1150-1155.
39. Wang XD, Liu C, Bronson RT, Smith DE, Krinsky NI, Russell M. Retinoid signaling and activator protein-1 expression in ferrets given beta-carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst. 1999;91:60-66.
40. Bazzano LA, He J, Ogden LG, et al. Dietary intake of folate and risk of stroke in US men and women: NHANES I Epidemiologic Follow-up Study. Stroke. 2002;33:1183-1188.
41. Harker LA, Ross R, Slichter SJ, Scott CR. Homocystine-induced arteriosclerosis: the role of endothelial cell injury and platelet response in its genesis. J Clin Invest. 1976;58:731-741.
42. Harker LA, Slichter SJ, Scott CR, Ross R. Homocystinemia: vascular injury and arterial thrombosis. N Engl J Med. 1974;291:537-543.
43. Malinow MR, Bostom AG, Krauss RM. Homocyst (e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation. 1999; 99:178-182.
44. Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med. 1999;131:363-375.
45. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338:131-137.
46. Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med. 1999;340:1449-1454.
47. Voutilainen S, Virtanen JK, Rissanen TH, et al. Serum folate and homocysteine and the incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr. 2004;80:317-323.
48. Hung J, Beilby JP, Knuiman MW, Divitini M. Folate and vitamin B-12 and risk of fatal cardiovascular disease: cohort study from Busselton, Western Australia. BMJ. 2003;326:131.
49. Brilakis ES, McConnell JP, Ballman KV, Klee GG, Berger PB. Lack of association between plasma homocysteine and angiographic coronary artery disease in the era of fortification of cereal grain flour with folic acid. Atherosclerosis. 2002;165:375-381.
50. Al-Delaimy WK, Rexrode KM, Hu FB, et al. Folate intake and risk of stroke among women. Stroke. 2004;35:1259-1263.
51. Toole JF, Malinow MR, Chambless LE, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA. 2004; 291:565-575.
52. Lange H, Suryapranata H, De Luca G, et al. Folate therapy and in-stent restenosis after coronary stenting. N Engl J Med. 2004;350:2673-2681.
53. Morris MC, Evans DA, Bienias JL, et al. Dietary folate and vitamin B12 intake and cognitive decline among community-dwelling older persons. Arch Neurol. 2005;62:641-645.
54. 12. Washington, DC: National Academy of Sciences; 1998.
55. Dhar M, Bellevue R, Carmel R. Pernicious anemia with neuropsychiatric dysfunction in a patient with sickle cell anemia treated with folate supplementation. N Engl J Med. 2003;348:2204-2207.
56. Brown BG, Zhao XQ, Chait A, et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med. 2001;345:1583-1592.
57. Brown BG, Cheung MC, Lee AC, Zhao XQ, Chait A. Antioxidant vitamins and lipid therapy: end of a long romance? Arterioscler Thromb Vasc Biol. 2002;22: 1535-1546.
58. Meydani SN, Leka LS, Fine BC, et al. Vitamin E and respiratory tract infections in elderly nursing home residents: a randomized controlled trial. JAMA. 2004; 292:828-836.
59. Pallast EG, Schouten EG, de Waart FG, et al. Effect of 50- and 100-mg vitamin E supplements on cellular immune function in noninstitutionalized elderly persons. Am J Clin Nutr. 1999;69:1273-1281.
60. Herbert V. Vitamin E supplementation and immune response in elderly patients [letter]. JAMA. 1998; 279:505.
61. Pan M, Cederbaum AI, Zhang YL, Ginsberg HN, Williams KJ, Fisher EA. Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J Clin Invest. 2004;113: 1277-1287.
62. Miller ER III, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: highdosage vitamin E supplementation may increase allcause mortality. Ann Intern Med. 2005;142:37-46.
63. Carpenter TO, Pettifor JM, Russell RM, et al. Severe hypervitaminosis A in siblings: evidence of variable tolerance to retinol intake. J Pediatr. 1987;111: 507-512.
64. Niacin intoxication from pumpernickel bagels: New York.MMWRMorb Mortal Wkly Rep. 1983;32:305.
65. Blank S, Scanlon KS, Sinks TH, Lett S, Falk H. An outbreak of hypervitaminosis D associated with the overfortification of milk from a home-delivery dairy. Am J Public Health. 1995;85:656-659.
66. Jacobus CH, Holick MF, Shao Q, et al. Hypervitaminosis D associated with drinking milk. N Engl J Med. 1992;326:1173-1177.
67. Hallberg L, Brune M, Erlandsson M, Sandberg AS, Rossander-Hulten L. Calcium: effect of different amounts on nonheme- and heme-iron absorption in humans. Am J Clin Nutr. 1991;53:112-119.
68. Solomons NW. Factors affecting the bioavailability of zinc. J Am Diet Assoc. 1982;80:115-121.
69. Institute of Medicine. Dietary Reference Intakes: Zinc. Washington, DC: National Academy of Sciences; 2001.
70. Corrigan JJ Jr, Ulfers LL. Effect of vitamin E on prothrombin levels in warfarin-induced vitamin K deficiency. Am J Clin Nutr. 1981;34:1701-1705.
71. Disler PB, Lynch SR, Charlton RW, et al. The effect of tea on iron absorption. Gut. 1975;16:193-200.
72. Molldrem KL, Li J, Simon PW, Tanumihardjo SA. Lutein and beta-carotene from lutein-containing yellow carrots are bioavailable in humans.Am J Clin Nutr. 2004;80:131-136.
73. Kostic D, White WS, Olson JA. Intestinal absorption, serum clearance, and interactions between lutein and beta-carotene when administered to human adults in separate or combined oral doses. Am J Clin Nutr. 1995;62:604-610.
74. Huang HY, Appel LJ. Supplementation of diets with alpha-tocopherol reduces serum concentrations of gamma- and delta-tocopherol in humans. J Nutr. 2003; 133:3137-3140.
75. Olmedilla B, Granado F, Southon S, et al. A European multicentre, placebo-controlled supplementation study with alpha-tocopherol, carotene-rich palm oil, lutein or lycopene: analysis of serum responses. Clin Sci. 2002;102:447-456.
76. McCay PB. Vitamin E: interactions with free radicals and ascorbate. Annu Rev Nutr. 1985;5:323-340.
77. Yeum KJ, Russell RM, Krinsky NI, Aldini G. Biomarkers of antioxidant capacity in the hydrophilic and lipophilic compartments of human plasma. Arch Biochem Biophys. 2004;430:97-103.
78. Teucher B, Olivares M, Cori H. Enhancers of iron absorption: ascorbic acid and other organic acids Int J Vitam Nutr Res. 2004;74:403-419.
79. Yuzbasiyan-Gurkan V, Grider A, Nostrant T, Cousins RJ, Brewer GJ. Treatment of Wilson's disease with zinc, X: intestinal metallothionein induction. J Lab Clin Med. 1992;120:380-386.
80. Hannon-Fletcher MP, Armstrong NC, Scott JM, et al. Determining bioavailability of food folates in a controlled interventions study. Am J Clin Nutr. 2004; 80:911-918.
81. Sanderson P, McNulty H, Mastroiacovo P, et al. Folate bioavailability: UK Food Standards Agency workshop report. Br J Nutr. 2003;90:473-479.
82. Brown ED, Micozzi MS, Craft NE, et al. Plasma carotenoids in normal men after a single ingestion of vegetables or purified beta-carotene. Am J Clin Nutr. 1989;49:1258-1265.
83. Haskell MJ, Jamil KM, Hassan F, et al. Daily consumption of Indian spinach (Basella alba) or sweet potatoes has a positive effect on total-body vitamin A stores in Bangladeshi men. Am J Clin Nutr. 2004;80: 705-714.
84. Tang G, Gu X, Hu S, et al. Green and yellow vegetables can maintain body stores of vitamin A in Chinese children. Am J Clin Nutr. 1999;70:1069-1076.
85. Sies H, Stahl W. Lycopene: antioxidant and biological effects and its bioavailability in the human. Proc Soc Exp Biol Med. 1998;218:121-124.
86. Mercke Odeberg J, Lignell A, Pettersson A, Hoglund P. Oral bioavailability of the antioxidant astaxanthin in humans is enhanced by incorporation of lipid based formulations. Eur J Pharm Sci. 2003;19:299-304.
87. Brown MJ, Ferruzzi MG, Nguyen ML, et al. Carotenoid bioavailability is higher from salads ingested with full-fat than with fat-reduced salad dressings as measured with electrochemical detection. Am J Clin Nutr. 2004;80:396-403.
88. Roodenburg AJ, Leenen R, van het Hof KH, Weststrate JA, Tijburg LB. Amount of fat in the diet affects bioavailability of lutein esters but not of alphacarotene, beta-carotene, and vitamin E in humans.Am J Clin Nutr. 2000;71:1187-1193.
89. Castenmiller JJ, West CE, Linssen JP. van het Hof KH, Voragen AG. The food matrix of spinach is a limiting factor in determining the bioavailability of betacarotene and to a lesser extent of lutein in humans. J Nutr. 1999;129:349-355.
90. Livny O, Reifen R, Levy I, et al. Beta-carotene bioavailability from differently processed carrot meals in human ileostomy volunteers. Eur J Nutr. 2003;42:338-345.
91. Stahl W, Sies H. Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans. J Nutr. 1992;122:2161-2166.
92. Sandberg AS. Bioavailability of minerals in legumes. Br J Nutr. 2002;88:S281-S285.
93. Reinhold JG, Parsa A, Karimian N, Hammick JW, Ismail-Beigi F. Availability of zinc in leavened and unleavened wholemeal wheaten breads as measured by solubility and uptake by rat intestine in vitro. J Nutr. 1974;104:976-982.
94. Carter EG, Carpenter KJ. The bioavailability for humans of bound niacin from wheat bran. Am J Clin Nutr. 1982;36:855-861.
95. Chung HY, Rasmussen HM, Johnson EJ. Lutein bioavailability is higher from lutein-enriched eggs than from supplements and spinach in men. J Nutr. 2004; 134:1887-1893.
96. Greger JL. Nondigestible carbohydrates and mineral bioavailability. J Nutr. 1999;129(7 suppl): 1434S-1435S.
97. Milman N, Pedersen AN, Ovesen L, Schroll M. Iron status in 358 apparently healthy 80-year-old Danish men and women: relation to food composition and dietary and supplemental iron intake. Ann Hematol. 2004;83:423-429.
98. Willcox JK, Catignani GL, Lazarus S. Tomatoes and cardiovascular health. Crit Rev Food Sci Nutr. 2003;43: 1-18.
99. Hu FB, Rimm EB, Stampfer MJ, Ascherio A, Spiegelman D, Willett WC. Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr. 2000;72:912-921.
100. Strandhagen E, Hansson PO, Bosaeus I, Isaksson B, Eriksson H. High fruit intake may reduce mortality among middle-aged and elderly men: the Study of Men Born in 1913. Eur J Clin Nutr. 2000;54:337-341.
101. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc. 1996; 96:1027-1039.
102. Alberts DS, Martinez ME, Roe DJ, et al; Phoenix Colon Cancer Prevention Physicians' Network. Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. N Engl J Med. 2000; 342:1156-1162.
103. Schatzkin A, Lanza E, Corle D, et al; Polyp Prevention Trial Study Group. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. N Engl J Med. 2000;342:1149-1155.
104. Braam L, McKeown NM, Jacques PF, et al. Dietary phylloquinone intake as a potential marker for a heart-healthy dietary pattern in the Framingham Offspring Cohort. J Am Diet Assoc. 2004;104: 1410-1414.
105. Erkkilä AT, Booth SL, Hu FB, et al. Phylloquinone intake as a marker for coronary heart disease risk but not stroke in women. Eur J Clin Nutr. 2005;59:196-204.
106. Boileau TW, Liao Z, Kim S, Lemeshow S, Erdman JW Jr, Clinton SK. Prostate carcinogenesis in Nmethyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets. J Natl Cancer Inst. 2003;95:1578-1586.
107. Lu QJ, Huang CY, Yao SX, Wang RS, Wu XN. Effects of fat-soluble extracts from vegetable powder and beta-carotene on proliferation and apoptosis of lung cancer cell YTMLC-90. Biomed Environ Sci. 2003;16:237-245.
108. Dragsted LO, Pedersen A, Hermetter A, et al. The 6-a-day study: effects of fruit and vegetables on markers of oxidative stress and antioxidative defense in healthy nonsmokers.Am J Clin Nutr. 2004;79:1060-1072.
109. Jasti S, Siega-Riz AM, Bentley ME. Dietary supplement use in the context of health disparities: cultural, ethnic and demographic determinants of use. J Nutr. 2003;133:2010S-2013S.
110. Pelletier DL, Kendall A. Supplement use may not be associated with better food intake in all population groups. Fam Econ Nutr Rev. 1997;10: 32-44.
111. Slesinski MJ, Subar AF, Kahle LL. Trends in use of vitamin and mineral supplements in the United States: the 1987 and 1992 National Health Interview Surveys. J Am Diet Assoc. 1995;95:921-923.
112. Levy AS, Schucker RE. Patterns of nutrient intake among dietary supplement users: attitudinal and behavioral correlates. J Am Diet Assoc. 1987;87:754-760.
113. Koplan JP, Annest JL, Layde PM, Rubin GL. Nutrient intake and supplementation in the United States (NHANES II). Am J Public Health. 1986;76: 287-289.
114. Osganian SK, Stampfer MJ, Rimm E, et al. Vitamin C and risk of coronary heart disease in women. J Am Coll Cardiol. 2003;42:246-252.
115. Use of vitamins containing folic acid among women of childbearing age-United States, 2004. MMWR Morb Mortal Wkly Rep. 2004;53:847-850.
116. Feskanich D, Singh V, Willett WC, Colditz GA. Vitamin A intake and hip fractures among postmenopausal women. JAMA. 2002;287:47-54.
117. US Department of Health and Human Services, US Department of Agriculture. Dietary Guidelines for Americans, 2005. Washington, DC: US Dept of Health and Human Services; 2005.
118. Dawson DW, Sawers AH, Sharma RK. Malabsorption of protein bound vitamin B12. BMJ. 1984;288: 675-678.
119. MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest. 1985;76:1536-1538.
120. Institute of Medicine. Dietary Reference Intakes: Calcium and Vitamin D. Washington, DC: National Academy of Sciences; 1997.
121. American Academy of Pediatric Dentistry. Clinical guideline on fluoride therapy. Pediatr Dent. 2004; 26:87-88.
122. Kris-Etherton PM, Harris WS, Appel LJ; American Heart Association Nutrition Committee. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002;106: 2747-2757.
123. Ordovas JM, Corella D. Nutritional genomics. Annu Rev Genomics Hum Genet. 2004;5:71-118.
124. Girelli D, Martinelli N, Pizzolo F, et al. The interaction between MTHFR 677 C→T genotype and folate status is a determinant of coronary atherosclerosis risk. J Nutr. 2003;133:1281-1285.
125. Kruger WD, Evans AA, Wang L, et al. Polymorphisms in the CBS gene associated with decreased risk of coronary artery disease and increased responsiveness to total homocysteine lowering by folic acid. Mol Genet Metab. 2000;70:53-60.